In the latest of our Climate Talks, former British Prime Minister Tony Blair and US Special Presidential Envoy for Climate, John Kerry, called for ambition to be matched by action, as the Science Museum Group’s Communications Director, Pete Dickinson describes.
In a once-in-a-lifetime acquisition for the nation, the remarkable contents of Professor Stephen Hawking’s office – including his personal reference library, innovative wheelchairs and communications equipment, medals, memorabilia and even the office furniture – will join the Science Museum Group Collection.
The world’s biggest vaccine manufacturer is the Serum Institute of India. Roger Highfield, Science Director, talks to Umesh Shaligram, Executive Director, about its vast COVID-19 vaccination effort.
Roger Highfield, Science Director, discusses two new COVID-19 vaccines under development, one of which is manufactured by cells from the fall armyworm moth, with Dr Ian Gray, Medical Director of Sanofi UK and Ireland.
How do you ensure that ‘COVID-19 jabs are in arms, not fridges’? Roger Highfield, Science Director, talks to Dr Emily Lawson, England’s vaccine deployment lead in the National Health Service.
How do you know which vaccine research to back when a pandemic starts? Roger Highfield, Science Director, talks to Kate Bingham, former chair of the UK Government’s Vaccine Taskforce.
A traditional kind of vaccine is being readied for the fight against the COVID-19 pandemic. Roger Highfield, Science Director, finds out about Europe’s first ‘inactivated virus’ vaccine.
Roger Highfield, Science Director, talks to the scientist behind the world’s first COVID-19 vaccine that requires only a single dose.
In celebration of the International Day of Women and Girls in Science on 11 February, Science Museum Group’s Director of Learning Susan Raikes outlines the importance of encouraging women and girls into careers in STEM (Science, Technology, Engineering, Maths) and highlights some of the many roles available.
For the first time, scientists can see a pandemic evolve in real time at the genetic level, revealing ‘variants of concern’ while guarding for large-scale genetic changes in COVID-19 that might occur by a process called recombination.